Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ DCP2 Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA566100
Description
Immunogen sequence: GLQPAKQQNSL MKCEKKLHPR KLQDNFETDA VYDLPSSSED QLLEHAEGQP VACNGHCKFP FSSRAFLSFK FDHNAIMKIL DL Highest antigen sequence identity to the following orthologs - mouse 82%, rat 83%.
The removal, or decapping, of eukaryotic mRNA is an important step in the degradation of mRNA. Decapping protein 2 (DCP2) is the major mRNA decapping enzyme in cells. It is a member of the Nudix hydrolases superfamily of proteins that predominantly catalyze the hydrolysis of small nucleoside diphosphate substrates linked to another moiety. DCP2 is widely expressed in multiple tissues at varying levels, with highest expression seen in testis and brain.
Specifications
DCP2 | |
Polyclonal | |
Unconjugated | |
DCP2 | |
2410015D23Rik; 5730537H01Rik; AL118268; DCP2; DCP2 decapping enzyme homolog; DCP2 decapping enzyme homolog (S. cerevisiae); decapping mRNA 2; Decapping protein 2; DFLJ33245; hDpc; m7GpppN-mRNA hydrolase; mRNA decapping enzyme 2; mRNA-decapping enzyme 2; Nucleoside diphosphate-linked moiety X motif 20; nudix (nucleoside diphosphate linked moiety X)-type motif 20; nudix (nucleoside diphosphate linked moiety X)-type motif 20 (NUDT20); Nudix motif 20; nudix-type motif 20; NUDT20; RGD1562909 | |
Rabbit | |
Antigen affinity chromatography | |
RUO | |
167227 | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
Liquid |
Immunocytochemistry | |
0.1 mg/mL | |
PBS with 40% glycerol and 0.02% sodium azide; pH 7.2 | |
Q8IU60 | |
DCP2 | |
Recombinant Human DCP2. Recombinant protein control fragment (Product #RP-106794). | |
100 μL | |
Primary | |
Human | |
Antibody | |
IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction